Correction: Suramin: A Potential Therapy for Diabetic Nephropathy.

Correction: Suramin: A Potential Therapy for Diabetic Nephropathy.

Bibliographic Details
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2014-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4237508

Similar Items

Correction: Suramin: A Potential Therapy for Diabetic Nephropathy
by: The Staff
Published: (2014-01-01)

Suramin: a potential therapy for diabetic nephropathy.
by: Midhun C Korrapati, et al.
Published: (2013-01-01)

Synthesis and biological assays at the D2 dopamine receptor of suramin and suramin analogues
by: Meneveau-Cardonnel, Caroline
Published: (2009)

Translational Research: Using Suramin as a Platform
by: Shen, Tong
Published: (2010)

Suramin Inhibits Chikungunya Virus Entry and Transmission.
by: Yi-Jung Ho, et al.
Published: (2015-01-01)

Translational Research of Suramin as a Chemosensitizer in Pancreatic Cancer
by: Li, Jing
Published: (2009)

Effect of suramin on urinary excretion of diabetes-induced glomerular and tubular injury parameters in rats
by: K. Sałaga-Zaleska, et al.
Published: (2021-07-01)

Suramin inhibits Hsp104 ATPase and disaggregase activity.
by: Mariana P Torrente, et al.
Published: (2014-01-01)

Delayed administration of suramin attenuates peritoneal fibrosis in rats
by: Chongxiang Xiong, et al.
Published: (2019-11-01)

Suramin alleviates glomerular injury and inflammation in the remnant kidney.
by: Na Liu, et al.
Published: (2012-01-01)

Suramin-Induced Neurotoxicity: Preclinical Models and Neuroprotective Strategies
by: David von der Ahe, et al.
Published: (2018-02-01)

Effect of suramin on myotoxicity of some crotalid snake venoms
by: E.Z. Arruda, et al.
Published: (2002-06-01)

1984—Discovery of the First Anti-HIV Drug, Suramin
by: Erik De Clercq
Published: (2021-08-01)

Suramin as a chemo- and radio-sensitizer: preclinical translational studies
by: Xin, Yan
Published: (2006)

SURAMIN AS AN INHIBITOR OF SYMPATHETIC EXCITATORY. JUNCTION POTENTIALS: STUDY IN GUINEA PIG ISOLATED VAS DEFERENS
by: M AYATOLLAHI
Published: (2001-06-01)

The beneficial effect of suramin on monocrotaline-induced pulmonary hypertension in rats.
by: Mohamed Izikki, et al.
Published: (2013-01-01)

Functionalized Periodic Mesoporous Organosilica Nanoparticles for Loading and Delivery of Suramin
by: Nikola Ž. Knežević, et al.
Published: (2019-02-01)

Cardiac ryanodine receptor modulation by suramin and structurally related compounds
by: Hill, Adam Parker
Published: (2003)

Design and Synthesis of Suramin Derivatives as New Anti–Noroviral Agents
by: 蔡沂晉
Published: (2013)

Structural Basis of Inhibition of the Pioneer Transcription Factor NF-Y by Suramin
by: Valentina Nardone, et al.
Published: (2020-10-01)

Exploring of anti-chikungunya virus drugs: development and mechanistic study of suramin
by: Yi-Jung Ho, et al.
Published: (2015)

Antiangiogenic Therapy for Diabetic Nephropathy
by: Katsuyuki Tanabe, et al.
Published: (2017-01-01)

Diabetic Nephropathy and Nutritional Therapy
by: D.D. Ivanov
Published: (2012-05-01)

In vivo experiments demonstrate the potent antileishmanial efficacy of repurposed suramin in visceral leishmaniasis.
by: Supriya Khanra, et al.
Published: (2020-08-01)

Study on complex structure between human interleukin-1α and suramin by NMR
by: Wang, Man-Hui, et al.
Published: (2010)

Effects of Suramin and Reactive blue-2 on the Release of Neurotransmitter from Motor Nerve
by: Liao,Fen-Fen, et al.
Published: (1996)

Mesenchymal Stem Cells: An Overview of Their Potential in Cell-Based Therapy for Diabetic Nephropathy
by: Yan Wu, et al.
Published: (2021-01-01)

Purinergic Receptor Blockade with Suramin Increases Survival of Postnatal Neural Progenitor Cells In Vitro
by: Alejandro Herrera, et al.
Published: (2021-01-01)

Suramin Inhibits Chikungunya Virus Replication by Interacting with Virions and Blocking the Early Steps of Infection
by: Irina C. Albulescu, et al.
Published: (2020-03-01)

Suramin attenuates intervertebral disc degeneration by inhibiting NF-κB signalling pathway
by: Zi-Miao Liu, et al.
Published: (2021-08-01)

Studies on suramin resistance in Kenyan stocks of Trypanosoma evansi (Steel, 1885 Balbiani, 1888)
by: Mutugi, Marion Wanjiku
Published: (1993)

The Potential Risk Factors In The Development Of Diabetic Nephropathy
by: Hsu, Yuehying, et al.
Published: (2011)

Structural bases of norovirus RNA dependent RNA polymerase inhibition by novel suramin-related compounds.
by: Romina Croci, et al.
Published: (2014-01-01)

Suramin Targets the Conserved Ligand-Binding Pocket of Human Raf1 Kinase Inhibitory Protein
by: Chenyun Guo, et al.
Published: (2021-02-01)

Repurposing Drugs for Mayaro Virus: Identification of EIDD-1931, Favipiravir and Suramin as Mayaro Virus Inhibitors
by: Lana Langendries, et al.
Published: (2021-03-01)

Antiinflammatory Actions of Klotho: Implications for Therapy of Diabetic Nephropathy
by: Marlena Typiak, et al.
Published: (2021-01-01)

Noncoding RNAs in Diabetic Nephropathy: Pathogenesis, Biomarkers, and Therapy
by: Jiarong Lv, et al.
Published: (2020-01-01)

Diabetic nephropathy. Is renoprotection determined by the choice of hypoglycemic therapy?
by: A. Y. Babenko, et al.
Published: (2015-12-01)

The anti-parasitic agent suramin and several of its analogues are inhibitors of the DNA binding protein Mcm10
by: Carolyn N. Paulson, et al.
Published: (2019-08-01)

Suramin inhibits antibody binding to cell surface antigens and disrupts complement-mediated mesangial cell lysis
by: Honglan Piao, et al.
Published: (2016-12-01)